Q3 pharma report

By Jonah Comstock October 20, 2017
Pharma companies were fairly active in digital health in the third quarter of 2017, especially in the areas of diabetes and respiratory disease. Read on for a round-up of notable events. Diabetes management Abbott Diabetes Care had a big quarter for its Freestyle Libre system, both in the United States and abroad. First, in July, Abbott and Bigfoot Biomedical entered into an agreement to develop...

Editor's Pick